Status:
COMPLETED
Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
Brief Summary
This trial is conducted in Europe. The aim of this observational study is to evaluate the change in weight in type 2 diabetes patients using Levemir® or Insulatard® under normal clinical practice cond...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- HbA1c greater than 7.0% and/or hypoglycaemia
- variable FBG and/or weight increase
- the selection of the subjects will be at the discretion of the participating physician
Exclusion
- non-type 2 diabetes
- current treatment with Levemir® or Insulatard®
- hypersensitivity to Levemir® or Insulatard® or to any of the excipients
- women who are pregnant, breast feeding or have the intention of becoming pregnant within next 6 months
Key Trial Info
Start Date :
November 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
699 Patients enrolled
Trial Details
Trial ID
NCT00658099
Start Date
November 1 2007
End Date
June 1 2008
Last Update
January 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Bucharest, Romania, 010031